DarioHealth Corp. (DRIO)
NASDAQ: DRIO · Real-Time Price · USD
7.11
+0.02 (0.28%)
At close: Sep 12, 2025, 4:00 PM EDT
7.10
-0.01 (-0.14%)
After-hours: Sep 12, 2025, 7:09 PM EDT
DarioHealth Revenue
DarioHealth had revenue of $5.37M in the quarter ending June 30, 2025, a decrease of -14.16%. This brings the company's revenue in the last twelve months to $27.15M, up 41.79% year-over-year. In the year 2024, DarioHealth had annual revenue of $27.04M with 32.86% growth.
Revenue (ttm)
$27.15M
Revenue Growth
+41.79%
P/S Ratio
0.71
Revenue / Employee
$134,396
Employees
202
Market Cap
17.06M
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 27.04M | 6.69M | 32.86% |
Dec 31, 2023 | 20.35M | -7.30M | -26.41% |
Dec 31, 2022 | 27.66M | 7.14M | 34.82% |
Dec 31, 2021 | 20.51M | 12.94M | 170.76% |
Dec 31, 2020 | 7.58M | 17.00K | 0.22% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
UnitedHealth Group | 422.82B |
Johnson & Johnson | 90.63B |
Merck & Co. | 63.62B |
AbbVie | 58.33B |
AstraZeneca | 56.50B |
Novartis AG | 55.19B |
Eli Lilly and Company | 53.26B |
Novo Nordisk | 49.11B |
DRIO News
- 10 days ago - DarioHealth Issues Shareholder Update: Multi-Condition Leadership in Momentum Driven Digital Health Market - PRNewsWire
- 11 days ago - Dario Secures Five New Employer Contracts Across Cardiometabolic Suite Including its Largest Employer to Date, Contributing to Annual Recurring Revenues Beginning Q3 2025 - PRNewsWire
- 19 days ago - DarioHealth Announces 20-to-1 Reverse Stock Split - PRNewsWire
- 4 weeks ago - DarioHealth Corp. (DRIO) Q2 2025 Earnings Call Transcript - Seeking Alpha
- 4 weeks ago - DarioHealth Reports Second Quarter 2025 Financial and Operating Results - PRNewsWire
- 5 weeks ago - DarioHealth to Report Second Quarter 2025 Results on Tuesday, August 12, 2025 - PRNewsWire
- 2 months ago - Dario and GreenKey Health Announce Strategic Commercial Agreement to Transform Chronic Condition Management and Sleep Health for Payers Nationwide - PRNewsWire
- 2 months ago - Dario Unveils Groundbreaking GLP-1 and AI-Personalization Digital Health Findings - PRNewsWire